YEAR
- 2013.05.06 NF-E2 p45 is important for establishing normal function of platelets. Fujita R, Takayama-Tsujimoto M, Satoh H, Gutiérrez L, Aburatani H, Fujii S, Sarai A, Bresnick EH, Yamamoto M, Motohashi H.Mol. Cell. Biol. 2013 Jul;33(14):2659-70. doi: 10.1128/MCB.01274-12
- 2013.05.03 Androgen-responsive long noncoding RNA CTBP1-AS promotes prostate cancer. Takayama K, Horie-Inoue K, Katayama S, Suzuki T, Tsutsumi S, Ikeda K, Urano T, Fujimura T, Takagi K, Takahashi S, Homma Y, Ouchi Y, Aburatani H, Hayashizaki Y, Inoue S.EMBO J. 2013 Jun 12;32(12):1665-80. doi: 10.1038/emboj.2013.99
- 2013.04.17 Sperm-associated antigen 4, a novel hypoxia-inducible factor 1 target, regulates cytokinesis, and its expression correlates with the prognosis of renal cell carcinoma. Shoji K, Murayama T, Mimura I, Wada T, Kume H, Goto A, Ohse T, Tanaka T, Inagi R, van der Hoorn FA, Manabe I, Homma Y, Fukayama M, Sakurai T, Hasegawa T, Aburatani H, Kodama T, Nangaku M.Am. J. Pathol. 2013 Jun;182(6):2191-203. doi: 10.1016/j.ajpath.2013.02.024
- 2013.03.29 Evaluation of the asparagine synthetase level in leukemia cells by monoclonal antibodies. Kusano-Arai O, Iwanari H, Mochizuki Y, Nakata H, Kodama T, Kitoh T, Hamakubo T.Hybridoma (Larchmt). 2012 Oct;31(5):325-32. doi: 10.1089/hyb.2012.0014
- 2013.03.27 Structural basis for the drug extrusion mechanism by a MATE multidrug transporter. Tanaka Y, Hipolito CJ, Maturana AD, Ito K, Kuroda T, Higuchi T, Katoh T, Kato HE, Hattori M, Kumazaki K, Tsukazaki T, Ishitani R, Suga H, Nureki O.Nature. 2013 Apr 11;496(7444):247-51. doi: 10.1038/nature12014
- 2013.03.22 Enrichment of stem-like cell population comprises transformation ability of Epstein-Barr virus latent membrane protein 2A for non-transformed cells. Nakaya T, Kikuchi Y, Kunita A, Ishikawa S, Matsusaka K, Hino R, Aburatani H, Fukayama M.Virus Res. 2013 Jun;174(1-2):108-15. doi: 10.1016/j.virusres.2013.03.009
- 2013.03.20 Screening of liver-targeted drugs. Midorikawa Y, Sugiyama Y, Aburatani H.Expert Opin Drug Discov. 2008 Jun;3(6):643-54. doi: 10.1517/17460441.3.6.643
- 2013.03.14 Inhibition of histone demethylase JMJD1A improves anti-angiogenic therapy and reduces tumor-associated macrophages. Osawa T, Tsuchida R, Muramatsu M, Shimamura T, Wang F, Suehiro J, Kanki Y, Wada Y, Yuasa Y, Aburatani H, Miyano S, Minami T, Kodama T, Shibuya M.Cancer Res. 2013 May 15;73(10):3019-28. doi: 10.1158/0008-5472.CAN-12-3231
CLOSE